DeutschNewstral
Article
jdsupra.com on 2019-05-20 17:22
CMS Amends Regulations to Lower Drug Prices and Reduce Out-Of-Pocket Expenses in Medicare Advantage and Part D Prescription Drug Benefit Program
Related news
- CMS Proposes Revised Prescription Drug Regulations to Lower Drug Prices and Reduce Out of Pocket Expensesjdsupra.com
- CMS Finalizes Rule Requiring Prescription Drug Price Information in Direct-to-Consumer Television Advertisementsjdsupra.com
- CMS Final Rule Requires Prescription Drug Pricing Transparency in DTC Advertisingjdsupra.com
- CMS Proposes Requiring Prescription Drug Price Disclosure in Direct-to-Consumer Advertisingjdsupra.com
- CMS Issues Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expensesjdsupra.com
- Medicare Advantage Plans, Medicare Prescription Drug Plans and FEHBP Carriers Take Note: CMS and OPM Announce Actions to Address the Threat of Coronavirusjdsupra.com
- Blog Series Part 7: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021jdsupra.com
- Blog Series Part 6: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service and Medicaid Managed Care Programs for Years 2020 and 2021jdsupra.com
- Blog Series Part 3: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021jdsupra.com
- Blog Series Part 5: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021jdsupra.com
- Blog Series Part 2: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021jdsupra.com
- Blog Series: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021jdsupra.com
- Blog Series Part 4: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021jdsupra.com
- CMS Proposes Changes to Lower Drug Pricesjdsupra.com
- New York Prescription Drug Formulary Reform Implementationjdsupra.com
- CMS Finalizes Medicare Advantage and Part D Drug Pricing Rulejdsupra.com
- CMS Finalizes Changes to Medicaid Prescription Drug Rebate Programjdsupra.com
- Maryland’s Prescription Drug Affordability Board Bill Set to Take Effectjdsupra.com
- More Ill-conceived Remedies from Congress Regarding Prescription Drug Costsjdsupra.com
- Are States Trending Toward Prescription Drug Affordability Boards?jdsupra.com